This is to inform you that the Board of Directors of the Company at its Meeting held today i.e. 30th May, 2025 have passed the following resolution. 1. The Board of Directors of the Company has considered and approved the Standalone Audited Financial Results for the quarter and year ended 31st March, 2025 along with the, Statement of Asset and Liabilities, Result, Cash flow, Audit Report, declaration on unmodified opinion, MD/CFO certification.

pdf

Aarey Drugs & Pharmaceuticals Ltd.

30 May 2025, 06:20PM

65.64

1.99%

Company Update

Aarey Drugs & Pharmaceuticals Ltd - 524412 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Annual secretarial Compliance Report for the year ended on 31st March 2025

pdf

Aarey Drugs & Pharmaceuticals Ltd.

23 May 2025

65.64

1.99%

Company Update

Aarey Drugs & Pharmaceuticals Ltd - 524412 - Announcement under Regulation 30 (LODR)-Allotment

BSE India

Allotment of Convertible Warrants pursuant to Preferential Issue.

pdf

Aarey Drugs & Pharmaceuticals Ltd.

22 May 2025

65.64

1.99%

Board Meeting

Aarey Drugs & Pharmaceuticals Ltd - 524412 - Board Meeting Intimation for Board Meeting Intimation

BSE India

Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve This is to intimate that the meeting of the Board of Directors of the Company is scheduled to be held on Friday 30th May, 2025 to transact the following business: 1. To consider and approve the Audited Financial statement for the quarter and year ended 31st March, 2025. 2. Any other matter with consent of the Chair

pdf

Aarey Drugs & Pharmaceuticals Ltd.

08 May 2025

65.64

1.99%

Company Update

Aarey Drugs & Pharmaceuticals Ltd - 524412 - Reg 30 Of SEBI LODR

BSE India

Reg 30 of SEBI LODR

pdf

Is Aarey Drugs & Pharmaceuticals Ltd. worth buying?

85 Votes:

Buy 80.0%

Sell 15.29%

Hold 4.71%